未登录Efficacy and Safety of Fosmidomycin-Piperaquine as Nonartemisinin-Based Combination Therapy for Uncomplicated Falciparum Malaria: A Single-Arm, Age De-escalation Proof-of-Concept Study in Gabon
Mombo-Ngoma, Ghyslain; Remppis, Jonathan; Sievers, Moritz; Manego, Rella Zoleko; Endamne, Lilian; Kabwende, Lumeka; Veletzky, Luzia; The Trong Nguyen; Groger, Mirjam; Lotsch, Felix; Mischlinger, Johannes; Flohr, Lena; Kim, Johanna; Cattaneo, Chiara; Hutchinson, David; Duparc, Stephan; Moehrle, Joerg; Velavan, Thirumalaisamy P.; Lell, Bertrand; Ramharter, Michael; Adegnika, Ayola Akim; Mordmueller, Benjamin; Kremsner, Peter G. .png)
分享.png)
收藏Whole-Genome Sequencing to Evaluate the Resistance Landscape Following Antimalarial Treatment Failure With Fosmidomycin-ClindamycinGuggisberg, Ann M.; Sundararaman, Sesh A.; Lanaspa, Miguel; Moraleda, Cinta; Gonzalez, Raquel; Mayor, Alfredo; Cistero, Pau; Hutchinson, David; Kremsner, Peter G.; Hahn, Beatrice H.; Bassat, Quique; Odom, Audrey R. 分享 收藏 分享 收藏 分享 收藏 CHARACTERIZATION OF RESISTANCE MUTATIONS SELECTED IN VITRO BY THE NON-NUCLEOSIDE HCV POLYMERASE INHIBITORS ABT-333 AND ABT-072Koev, G.; Mondal, R.; Beyer, J.; Reisch, T.; Masse, S.; Kati, W.; Hutchinson, D.; Flentge, C.; Randolph, J.; Donner, P.; Krueger, A.; Wagner, R.; Yan, P.; Lin, T.; Maring, C.; Molla, A. 分享 收藏 PRECLINICAL POTENCY, PHARMACOKINETIC AND ADME CHARACTERIZATION OF ABT-333, A NOVEL NON-NUCLEOSIDE HCV POLYMERASE INHIBITORMaring, C.; Wagner, R.; Hutchinson, D.; Flentge, C.; Kati, W.; Koev, G.; Liu, Y.; Beno, D.; Shen, J.; Lau, Y. Y.; Gao, Y.; Fischer, J.; Vaidyanathan, S.; Lim, B. H.; Beyer, J.; Mondal, R.; Molla, A. 分享 收藏 分享 收藏 
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
